Migraine Study for Men or Women ages 18 to 65 Currently Using Triptans. (e.g., Almotriptan/Axert; Frovatriptan/Frova; Rizatriptan/Maxalt; Sumatriptan/Imitrex; Zolmitriptan/Zomig)

  • STATUS
    Recruiting
Updated on 8 November 2020

Summary

Migraine Study for Men or Women ages 18 to 65 Currently Using Triptans. (e.g., Almotriptan/Axert; Frovatriptan/Frova; Rizatriptan/Maxalt; Sumatriptan/Imitrex; Zolmitriptan/Zomig)

Description

A Multicenter, Open-Label Evaluation of Treatment Satisfaction, Tolerability, Safety, and Preference of Sumavel DosePro for Treatment of Migraine in Subjects Currently Treated with Triptans

Patient Inclusion Criteria:

  • Men or Women 18 to 65 years of age
  • Have a history of 2 to 6 migraine headaches (on average) per month
  • Suffering from Migraines for more than one (1) year before first office visit
  • Willing to stop or discontinue current treatment for Migraines Headaches
  • Diagnosis of Migraine Headaches before the age of 50
  • Be Fluent in English

Patient Exclusion Criteria:

  • Can not read or understand English Forms
  • History of Epilepsy or Seizure or any other Neurologic Condition
  • HIV/AIDS, Cancer or Hepatitis C (detectable or undetectable)
  • Hemiplegic or Basilar Migraines
  • Terminal Illnesses
  • Uncontrolled Cardiovascular Diseases (Uncontrolled Hypertension)
  • Minors (under the legal age of 18)
  • Older than the permitted age of 65

Details
Condition Migraine and Cluster Headaches
Clinical Study IdentifierTX134653
Last Modified on8 November 2020

Eligibility

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note